Sensitivity of fibroblasts derived from ataxia-telangiectasia patients to calicheamicin γ1I
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Treatment with calicheamicin gamma 1I reveals SV40-transformed fibroblasts derived from ataxia telangiectasia (AT) patients to be 6-fold more sensitive to this drug when compared to controls.
Abstract
We report the hypersensitivity of SV40-transformed fibroblasts derived from ataxia telangiectasia (AT) patients to calicheamicin gamma 1I. In common with other free-radical generating agents such as bleomycin and ionizing radiation, treatment with calicheamicin gamma 1I reveals AT derived lines to be 6-fold more sensitive to this drug when compared to controls. Furthermore, in common with ionizing radiation, AT cells did not show dose-dependent inhibition of DNA synthesis after treatment with calicheamicin gamma 1I.
